Schedule Update - effective 1 May 2009 (text extract)

This is the text extract for Schedule Update - effective 1 May 2009, browse documents here.

Pharmaceutical Management Agency

Update

New Zealand Pharmaceutical Schedule

Effective 1 May 2009 Section H cumulative for April and May 2009.

Contents

Summary of PHARMAC decision effective 1 May 2009.................................. 3 Changes to list of approved specialists for antiretroviral Special Authority applications .................................................................... 4 Discontinuation of trimipramine (Tripress) .................................................... 4 Terazosin hydrochloride – new brand fully subsidised ................................... 4 Changes to listing description ....................................................................... 5 Omprazole .................................................................................................... 5 Amendment to rule 8.6 of Section H of the Pharmaceutical Schedule .......... 5 Dextropropoxyphene with Paracetamol (Paradex and Capadex) .................... 6 Indomethacin ................................................................................................ 6 Atorvastatin 80 mg ....................................................................................... 6 Sole Subsidised Supply .................................................................................. 7 Looking Forward ........................................................................................... 7 Sole Subsidised Supply products cumulative to May 2009 ............................ 8 New Listings ................................................................................................ 17 Changes to Restrictions ............................................................................... 18 Changes to Subsidy and Manufacturer’s Price............................................. 19 Changes to Description ............................................................................... 21 Changes to Sole Subsidised Supply ............................................................. 21 Delisted Items ............................................................................................. 22 Items to be Delisted .................................................................................... 23 Section H changes to Part I ......................................................................... 24 Section H changes to Part II ........................................................................ 25 Section H changes to Part IV ....................................................................... 27 Index ........................................................................................................... 28

Summary of PharmaC decisions

effeCtIve 1 maY 2009 New listings (page 17) • Atorvastatin (Lipitor) tab 80 mg – Additional subsidy by Special Authority • Co-Trimoxazole (Deprim) oral liquid trimethoprim 40 mg and sulphamethoxazole 200 mg per 5 ml • Nortriptyline hydrochloride (Norpress) tab 25 mg – pack of 180 • Paclitaxel (Paclitaxel Ebewe) inj 30 mg – PCT only – Specialist – pack of 5 • Paediatric oral feed (NutriniDrink) liquid (strawberry and vanilla) 200 ml OP – Special Authority – Hospital pharmacy [HP3] • Paediatric oral feed with fibre (NutriniDrink Multifibre) liquid (strawberry, chocolate and vanilla) 200 ml OP – Special Authority – Hospital pharmacy [HP3] • Terazosin hydrochloride (Apo-Terazosin) tab 1 mg, 2 mg and 5 mg Changes to restrictions (page 18) • Furosemide (Diurin 40, Diurin 500, Lasix and Mayne) tab 40 mg and 500 mg, oral liq 10 mg per ml, inf and inj 10 mg per ml - change in chemical name • Ciclopiroxolamine (Batrafen) nail soln 8% - change of chemical name Decreased subsidy (pages 19 – 20) • Acarbose (Glucobay) tab 50 mg and 100 mg • Amoxycillin clavulanate (Augmentin) tab amoxycillin 500 mg with potassium clavulanate • Ciclopiroxolamine (Batrafen) nail sol 8% • Entacapone (Comtan) tab 200 mg • Erythromycin ethyl succinate (E-Mycin) tab 400 mg • Furosemide (Diurin 40) tab 40 mg • Hydroxychloroquine sulphate (Plaquenil) tab 200 mg • Ibuprofen (I-Profen) tab 200 mg • Methadone hydrochloride (Biodone) oral liq 2 mg per ml, (Biodone Forte) oral liq 5 mg per ml and (Biodone Extra Forte) oral liq 10 mg per ml • Simvastatin (Lipex and SimvaRex) tab 10 mg, 20 mg, 40 mg and (Lipex) 80 mg Increased subsidy (pages 19 – 20) • Calcium carbonate with aminoacetic acid (Titralac) tab 420 mg with aminoacetic acid 180 mg – pack of 100 • Simvastatin (SimvaRex) tab 80 mg

4 Pharmaceutical Schedule - Update News

Changes to list of approved specialists for antiretrorival Special Authority applications

Dr Deborah Williams (Dunedin) has returned to the United Kingdom; therefore, effective from 6 June 2009 (to allow processing of any non-filled prescriptions) her name will be removed from the list of approved specialists who can prescribe HIV antiretrovirals in New Zealand.

Discontinuation of trimipramine (Tripress)

Mylan New Zealand Ltd (formerly Pacific Pharmaceuticals) has advised that it is discontinuing supply of all funded strengths of the antidepressant trimipramine maleate (Tripress) capsules (25 mg and 50 mg). Stock of the 25 mg capsules is expected to run out by July 2009 and the 50 mg capsules are expected to run out by October 2009. PHARMAC will delist Tripress 25 mg and 50 mg from 1 April 2010. The supplier has written to clinicians advising them to switch patients currently on trimipramine to a clinically suitable alternative medication as soon as possible.

Terazosin Hydrochloride – new brand fully subsidised

As from 1 May 2009 the Apo-Terazosin brand of terazosin hydrochloride will be listed in the Pharmaceutical Schedule. All strengths, 1 mg, 2 mg and 5 mg will be available fully subsidised.

Pharmaceutical Schedule - Update News

Changes to listing description

There are two chemical name changes effective 1 May 2009: furosemide (previously frusemide) and ciclopiroxolamine (previously ciclopirox olamine) These changes from British Approved Names to International Nonproprietary Names are in line with current pharmacy dispensing practice. There is also a pack size name change for Benzathine benzylpenicillin (Bicilllin LA). Previously the label read as inj 1.2 mega u per 2ml however the actual volume in the prefilled syringe is 2.3 ml. In discussions between Aspen Pharmaceuticals Ltd and the TGA in Australia it was agreed that the packaging should reflect the actual volume in the prefilled syringe.

Omeprazole

From 1 May 2009, the Dr Reddy’s Omeprazole brand of omeprazole will be the only subsidised brand of omeprazole available. As part of the final transition to sole supply of omeprazole, the partial subsidy that has applied to Losec will be removed and Losec will be delisted from the Pharmaceutical Schedule. Patient leaflets remain available from PHARMAC to help explain this brand change to patients by calling 0800 66 00 50.

Amendment to rule 8.6 of Section H of the Pharmaceutical Schedule

Rule 8.6 of Section H of the Pharmaceutical Schedule will be amended from 1 May 2009. This rule change will allow District Health Board hospitals to dispense more than 5 days supply to out-patients provided that: (i) the DHB hospital has a dispensing for discharge policy and the quantity of medicine supplied is in accordance with that policy; and (ii) the medicine is supplied consistently with any restrictions applying to that Pharmaceutical in Section A-G of the Pharmaceutical Schedule. Any such dispensing for discharge will be funded from the DHBs hospital budget, as is the current situation, not from the Pharmaceutical Budget. Only those DHB hospitals with a dispensing for discharge policy may dispense more than 5 days medication. Previously DHB hospitals may only dispense up to 5 days supply or one original pack (where inappropriate to provide less).

6 Pharmaceutical Schedule - Update News

Dextropropoxyphene with paracetamol (Paradex and Capadex)

Last month we advised of a potential subsidy reduction on 1 May 2009 for both brands of dextropropoxyphene with paracetamol to the level of paracetamol 500 mg tablets. This proposal will not be happening from 1 May 2009; however, the proposal remains under consideration and may be implemented later this year.

Indomethacin

We have previously advised of the impending discontinuation of all funded strengths and presentations of indomethacin. In addition to our willingness to consider Exceptional Circumstances funding for the use of indomethacin in niche indications (chronic paroxysmal hemicrania and hemicrania continua, and reduction of glomerular filtration rate in children being treated for congenital nephrotic syndrome), we are now intending to include each presentation in the Discretionary Community Supply (DCS) list as it is discontinued, which would provide a mechanism for funded access to indomethacin for the most at-need patients should DHB hospitals be able to find a supplier. We have now received notification of discontinuation of indomethacin 50 mg capsules from 1 April 2009 (this will be delisted from the Pharmaceutical Schedule on 1 October 2009); thus, accordingly, indomethacin 50 mg capsules will be included on the DCS list from 1 May 2009.

Atorvastatin 80 mg

From 1 May 2009 an 80 mg tablet of atorvastatin (Lipitor) will be listed in the Pharmaceutical Schedule fully funded by Special Authority. As noted in the consultation letter a rebate arrangement applies to Lipitor 80 mg which has the effect of reducing the price of the 80 mg tablet to less than the price of two 40 mg atorvastatin tablets. We therefore encourage the use of one 80 mg tablet rather than two 40 mg tablets for patients who are prescribed an 80 mg dose.

Sole Subsidised Supply

Sole Subsidised Supply changes – effective 1 June 2009

Chemical Name Allopurinol Ditiazem hydrochloride Ditiazem hydrochloride Presentation; Pack size Tab 100 mg; 250 Tab 300 mg; 100 Tab 30 mg; 100 Tab 60 mg; 100 Cap long-acting 120 mg (once per day); 30 Cap long-acting 180 mg; 30 Cap long-acting 240 mg; 30 Inj 40 mg; 1 inj Sole Subsidised Supply brand (and supplier) Apo-Allopurinol (Apotex) Dilzem (Douglas) Cardizem CD (Sanofi-Aventis)

Pantoprazole

Pantocid I.V (API Consumer Brands)

Looking forward

This section is designed to alert both pharmacists and prescribers to possible future changes. It may assist pharmacists to manage stock levels and keep prescribers up-to-date with proposals to change the Pharmaceutical Schedule. Possible decisions for implementation 1 June 2009 • Acetylcysteine (Martindale Acetylcysteine) in 200 mg per ml – new listing

Sole Subsidised Supply Products – cumulative to May 2009

Generic Name

Acetazolamide Aciclovir Alprazolam

Presentation

Tab 250 mg; 100 tab Tab dispersible 200 mg Tab dispersible 400 mg Tab 250 µg Tab 500 µg Tab 1 mg Inj 10 mg per ml, 1 ml Cap 100 mg Tab 5 mg Tab 10 mg Drops 100 mg per ml; 30 ml OP Inj 250 mg; 10 pack Inj 500 mg; 10 pack Inj 1 g; 10 pack Cap 250 mg & 500 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Crm 500 g; pot Tab 100 mg Tab dispersible 300 mg Tab 100 mg Tab 50 mg & 100 mg Eye drops 1%; 15 ml OP Inj 600 µg, 1 ml Inj 1200 µg, 1 ml Tab 500 mg Metered aqueous nasal spray 50 µg Metered aqueous nasal spray 100 µg Inj 1 mega u; 10 inj Scalp app 0.1% Tab 200 mg; 90 tab Tab 50 mg Tab 5 mg Eye drops 0.2% Inj 0.5%, 4 ml Inj 0.5%, 8% glucose, 4 ml Lotion BP Crm, aqueous, BP Inj 100 iu per ml, 1 ml; 5 inj Cap 0.25 µg & 0.5 µg

Brand Name Expiry Date*

Diamox Lovir Lovir Arrow-Alprazolam Arrow-Alprazolam Arrow-Alprazolam Mayne Symmetrel Apo-Amlodipine Ospamox Ibiamox Apo-Amoxi Ranbaxy Amoxicillin Ranbaxy Amoxicillin AFT Apo-Ascorbic Acid Ethics Aspirin Ethics Aspirin EC Loten Atropt AstraZeneca AstraZeneca Arrow-Azithromycin Alanase Alanase Sandoz Beta Scalp Fibalip Bicalox Lax-Tab AFT Marcain Isobaric Marcain Heavy ABM ABM Miacalcic Calcitriol-AFT 2009 2010 2009 2011 2009 2009 2009 2011 2009 2011 2011 2010 2011 2010 2009 2011 2009 2011 2009 2010

Apomorphine hydrochloride Amantadine hydrochloride Amlodipine Amoxycillin

2009 2011 2011 2011

2010 2009

Aqueous cream Ascorbic acid Aspirin Atenolol Atropine sulphate

Azithromycin Beclomethasone dipropionate Benzylpenicillin sodium (Penicillin G) Betamethasone valerate Bezafibrate Bicalutamide Bisacodyl Brimonidine tartrate Bupivicaine hydrochloride Calamine Calcitonin Calcitriol

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 8

Sole Subsidised Supply Products – cumulative to May 2009

Generic Name

Calcium Calcium folinate Captopril Cefaclor monohydrate Cefazolin sodium Cefuroxime sodium Cetomacrogol Cetirizine hydrochloride Chloramphenicol Chlorhexidine gluconate

Presentation

Tab eff 1 g; 30 tab Inj 50 mg Tab 12.5 mg, 25 mg & 50 mg Cap 250 mg Grans for oral liq 125 mg per 5 ml Inj 500 mg Inj 1 g Inj 750 mg & 1.5 g Crm BP Tab 10 mg Oral liq 1 mg per ml; 200 ml Eye drops 0.5% Eye oint 1% Soln 4% Handrub 1% with ethanol 70% Mouthwash 0.2% Tab 25 mg Tab 250 mg Tab 500 mg Tab 750 mg Tab 20 mg; 84 pack Tab 250 mg Grans for oral liq 125 mg per 5 ml Crm 0.05% Tab 500 µg; 100 tab Tab 2 mg; 100 tab Vaginal crm 2%; 20 g OP Crm 1% Vaginal crm 1% with applicator(s) Tab 15 mg, 30 mg & 60 mg Tab 500 µg Sach 5 g Inj 150 mg Powder for soln for oral use Tab 50 mg Tab 50 mg Tab 50 mg Cap 25 mg & 50 mg Inj 500 mg

Brand Name Expiry Date*

Calsource Calcium Folinate Ebewe Apo-Captopril Ranbaxy Cefaclor Ranbaxy Cefaclor Hospira Zinacef PSM Zetop Cetirizine-AFT Chlorsig Chlorsig Orion Orion Orion Hygroton Rex Medical 2011 2011 2010 2010 2011 2011 2010 2011 2009 2011 2009 2009 2011

Chlorthalidone Ciprofloxacin

Citalopram Clarithromycin Clobetasol propionate Clonazepam Clotrimazole

Arrow-Citalopram Klamycin Klacid Dermol Paxam Paxam Clomazol Clomazol Clomazol PSM Colgout Colestid Colistin-Link Enerlyte Nausicalm Cycloblastin Siterone Dantrium Mayne

2010 2010 2009 2011 2010

Codeine phosphate Colchicine Colestipol hydrochloride Colistin sulphomethate Compound electrolytes Cyclizine hydrochloride Cyclophosphamide Cyproterone acetate Dantrolene sodium Desferrioxamine mesylate

2010 2010 2010 2010 2010 2009 2010 2009 2009 2010

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 9

Sole Subsidised Supply Products – cumulative to May 2009

Generic Name

Desmopressin Dexamethasone sodium phosphate Dexamphetamine sulphate Dextrose Dextrose with electrolytes

Presentation

Nasal spray 10 mcg per dose Inj 4 mg per ml, 1 ml Inj 4 mg per ml, 2 ml Tab 5 mg Inj 50%, 10 ml Oral soln with electrolytes

Brand Name Expiry Date*

Desmopressin-PH&T Mayne PSM Biomed Pedialyte – Plain Pedialyte – Bubblegum Pedialyte – Fruit Voltaren Ophtha Voltaren Voltaren Voltaren Voltaren Voltaren Apo-Diclo Apo-Diclo SR Videx EC Pytazen SR Apo-Doxazosin AFT m-Enalapril Mayne Cafergot E-Mycin E-Mycin New Zealand Medical and Scientific Brevinor 21 Brevinor 1/21 Brevinor 1/28 Vepesid Ferodan Fintral Flucloxin 2009 2010 2011 2011 2009 2010 2011 2009 2010 2011 2010

Diclofenac sodium

Eye drops 1 mg per ml Inj 25 mg per ml, 3 ml Suppos 12.5 mg Suppos 25 mg Suppos 50 mg Suppos 100 mg Tab EC 25 mg & 50 mg Tab long-acting 75 mg & 100 mg Cap 125 mg, 200 mg, 250 mg & 400 mg Tab long-acting 150 mg Tab 2 mg & 4 mg Oint BP Tab 5 mg, 10 mg & 20 mg Inj 500 µg per ml, 1 ml Tab 1 mg with caffeine 100 mg Grans for oral liq 200 mg per 5 ml; 100 ml Grans for oral liq 400 mg per 5 ml; 100 ml Tab 10 µg Tab 35 µg with norethisterone 500 µg Tab 35 µg with norethisterone 1 mg Tab 35 µg with norethisterone 1 mg and 7 inert tab Cap 50 mg & 100 mg Oral liq 150 mg per 5 ml Tab 5 mg; 30 tab Inj 250 mg; 10 pack Inj 500 mg; 10 pack Inj 1 g; 10 pack

2011

2009 2009 2011 2010 2011 2009 2009 2009 2011

Didanosine (DDI) Dipyridamole Doxazosin mesylate Emulsifying ointment Enalapril Ergometrine maleate Ergotamine tartrate with caffeine Erythromycin ethyl succinate

Ethinyloestradiol Ethinyloestradiol with norethisterone

Etoposide Ferrous sulphate Finasteride Flucloxacillin

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 10

Sole Subsidised Supply Products – cumulative to May 2009

Generic Name

Flucloxacillin sodium

Presentation

Cap 250 mg & 500 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap 50 mg Cap 150 mg Cap 200 mg Inj 50 mg Tab 10 mg Oint 950 µg, with fluocortolone pivalate 920 µg, and cinchocaine hydrochloride 5 mg per g Suppos 630 µg, with fluocortolone pivalate 610 µg, and cinchocaine hydrochloride 1 mg Eye drops 0.1% Cap 20 mg Tab disp 20 mg, scored Tab 0.8 mg & 5 mg Crm 2% & Oint 2% Inj 40 mg per ml, 2 ml Tab 80 mg Tab 5 mg Tab 600 µg Oral pump spray 400 µg per dose TDDS 5 mg TDDS 10 mg Oral liq 2 mg per ml Tab 500 µg, 1.5 mg & 5 mg Inj 5 mg per ml, 1 ml Inj 10 iu per ml, 5 ml Crm 1% Tab 5 mg & 20 mg Rectal foam 10%, CFC-Free Scalp lotn 0.1% Lotn 1% with wool fat hydrous 3% and mineral oil Eye drops 0.5% Inj 20 mg, 1 ml Tab 20 mg Oral liq 100 mg per 5 ml, 200 ml Tab 10 mg & 25 mg Tab 2.5 mg

Brand Name Expiry Date*

Staphlex AFT AFT Pacific Pacific Pacific Fludara Fludara Ultraproct Ultraproct 2009

Fluconazole

2011

Fludarabine phosphate Fluocortolone caproate with fluocortolone pivalate and cinchocaine

2011 2010

Fluorometholone Fluoxetine hydrochloride Folic Acid Fusidic acid Gentamicin sulphate Gliclazide Glipizide Glyceryl trinitrate

Flucon Fluox Fluox Apo-Folic Acid Foban Pfizer Apo-Gliclazide Minidiab Lycinate Nitrolingual pumpspray Nitroderm TTS 5 Nitroderm TTS 10 Serenace Serenace Serenace AstraZeneca PSM Douglas Colifoam Locoid DP Lotn HC Methopt Buscopan Gastrosoothe Fenpaed Tofranil Napamide

2009 2010 2009 2010 2009 2011 2011 2011

Haloperidol

2010 2009 2009 2011 2009 2009 2010 2011 2011 2011 2010 2009 2009

Heparinised saline Hydrocortisone Hydrocortisone acetate Hydrcortisone butyrate Hydrocortisone with wool fat and mineral oil Hypromellose Hysocine N-butylbromide Ibuprofen Imipramine hydrochloride Indapamide

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 11

Sole Subsidised Supply Products – cumulative to May 2009

Generic Name

Ipratropium bromide

Presentation

Aqueous nasal spray, 0.03% Nebuliser soln, 250 µg per ml, 1 ml Nebuliser soln, 250 µg per ml, 2 ml Inj 50 mg per ml, 2 ml Tab long-acting 60 mg Cap 10 mg Cap 20 mg Cap 100 mg Shampoo 2%, 100 ml OP Oral liq 10 g per 15 ml Eye drops 0.25% & 0.5% Cap 50 mg with benserazide 12.5 mg Tab dispersible 50 mg with benserazide 12.5 mg Cap 100 mg with benserazide 25 mg Cap long-acting 100 mg with benserazide 25 mg Cap 200 mg with benserazide 50 mg Inj 0.5%, 5 ml Inj 1%, 5 ml Inj 1%, 20 ml Crm 2.5% with prilocaine 2.5%; 30 g OP Crm 2.5% with prilocaine 2.5%; 5 g Tab 5 mg, 10 mg & 20 mg Tab 2 mg Tab 10 mg Oral liq 1 mg per ml

Brand Name Expiry Date*

Apo-Ipravent Ipratripium Steri-Neb Ipratripium Steri-Neb Ferrum H Duride Isotane 10 Isotane 20 Sporanox Sebizole Duphalac Betagan Madopar 62.5 Madopar Dispersible Madopar 125 Madopar HBS Madopar 250 Xylocaine Xylocaine Xylocaine EMLA EMLA Arrow-Lisinopril Nodia Loraclear Hayfever Relief Lorapaed Ativan Mayne Derbac M A-Lices Ludiomil Colofac Provera Pentasa Arrow-Metformin Methatabs AFT 2009 2010 2010 2010 2010

Iron polymaltose Isosorbide mononitrate Isotretinoin Itraconazole Ketoconazole Lactulose Levobunolol Levodopa with benserazide

2011 2009 2009 2010 2011 2010 2010 2009

Lignocaine hydrochloride

Lignocaine with prilocaine

2010

Lisinopril Loperamide hydrochloride Loratadine

Lorazepam Magnesium sulphate Malathion Maldison Maprotiline hydrochloride Mebeverine hydrochloride Medroxyprogesterone acetate Mesalazine Metformin hydrochloride Methadone hydrochloride

Tab 1 mg & 2.5 mg Inj 49.3% Liq 0.5% Shampoo 1% Tab 25 mg & 75 mg Tab 135 mg; 90 tab Tab 2.5 mg, 5 mg, 10 mg, 100 mg & 200 mg Enema 1 g per 100 ml Tab 500 mg & 850 mg Tab 5 mg Powder 1 g

2009 2009 2010 2010 2009 2011 2010 2009 2009 2010 2009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 12

Sole Subsidised Supply Products – cumulative to May 2009

Generic Name

Methotrexate

Presentation

Inj 100 mg per ml, 10 ml Inj 100 mg per ml, 50 ml Tab 2.5 mg & 10 mg Tab 125 mg; 100 tab Tab 250 mg; 100 tab Tab 500 mg; 100 tab Tab long-acting 20 mg Tab 5 mg & 20 mg Tab 10 mg Tab 4 mg & 100 mg Crm 0.1% and oint 0.1% Inj 40 mg per ml, 1 ml Inj 40 mg per ml with lignocaine 1 ml Inj 40 mg per ml, 1 ml Inj 62.5 mg per ml, 1 ml Inj 500 mg & 1 g Inj 5 mg per ml, 2 ml Tab long-acting 200 mg Cap 250 mg Crm 2% Tab 2.5 mg & 5 mg Tab 200 µg Tab 150 mg & 300 mg Oral liq 1 mg per ml Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Inj 10 mg per ml, 1 ml Inj 30 mg per ml, 1 ml Inj 5 mg per ml, 1 ml Inj 15 mg per ml, 1 ml Cap long-acting 10 mg, 30 mg, 60 mg, 100 mg & 200 mg Tab immediate release 10 mg & 20 mg Inj 80 mg per ml, 1.5 ml & 5 ml Tab 40 mg & 80 mg Tab 50 mg Tab 250 mg Tab 500 mg

Brand Name Expiry Date*

Methotrexate Ebewe Methotrexate Ebewe Methoblastin Prodopa Prodopa Prodopa Rubifen SR Rubifen Rubifen Medrol Advantan Depo-Medrol Depo-Medrol with Lidocaine Solu-Medrol Solu-Medrol Solu-Medrol Pfizer Slow-Lopresor Metopirone Multichem Gutron Cytotec Apo-Moclobemide RA-Morph RA-Morph RA-Morph RA-Morph Mayne Mayne Mayne Mayne m-Eslon Sevredol Mayne Apo-Nadolol ReVia Noflam 250 Noflam 500 2009 2010 2010 2009 2011 2009 2011

Methyldopa

Methylphenidate hydrochloride

2009

Methylprednisolone Methylprednisolone aceponate Methylprednisolone acetate Methylprednisolone acetate with lignocaine Methylprednisolone sodium succinate Metoclopramide hydrochloride Metoprolol tartrate Metyrapone Miconazole nitrate Midodrine Misoprostol Moclobemide Morphine hydrochloride

2009 2009 2011 2011 2009

2011 2009 2009 2011 2009 2009 2009 2009

Morphine sulphate

2011 2009

Morphine tartrate Nadolol Naltrexone hydrochloride Naproxen

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 13

Sole Subsidised Supply Products – cumulative to May 2009

Generic Name

Naproxen sodium Neostigmine Nevirapine Nicotinic acid Nifedipine Norethisterone Nortriptyline hydrochloride Nystatin

Presentation

Tab 275 mg Inj 2.5 mg per ml, 1 ml Oral suspension 10 mg per ml Tab 50 mg & 500 mg Tab long-acting 20 mg Tab 5 mg Tab 350 µg Tab 10 mg; 100 tab Tab 25 mg; 250 tab Oral liq 100,000 u per ml, 24 ml OP Cap 500,000 u Tab 500,000 u Vaginal crm 100,000 u per 5 g with applicators Tab 4 mg & 8 mg Tab disp 4 mg & 8 mg Tab 5 mg Oral liq 5 mg per 5 ml Inj 10 mg per ml, 1 ml and 2 ml Oral liq 5 mg per 5 ml Inj 5 iu per ml, 1 ml Inj 10 iu per ml, 1 ml Inj 5 iu with ergometrine maleate 500 µg per ml, 1 ml Inj 3 mg per ml, 5 ml Inj 3 mg per ml, 10 ml Inj 6 mg per ml, 10 ml Tab 20 mg Tab 40 mg

Brand Name Expiry Date*

Sonaflam AstraZeneca Viramune Suspension Apo-Nicotinic Acid Nyefax Retard Primolut N Noriday 28 Norpress Norpress Nilstat Nilstat Nilstat Nilstat Zofran Zofran Zydis Apo-Oxybutynin Apo-Oxybutynin OxyNorm OxyNorm Syntocinon Syntocinon Syntometrine Pamisol Pamisol Pamisol Dr Reddy’s Pantoprazole Dr Reddy’s Pantoprazole Pharmacare Paracetamol Paracare Junior Paracare Double Strength Lacri-Lube Loxamine Permax Permax Pexsig 2010 2010 2009 2009 2009 2011 2009 2011 2011 2010 2009 2010 2010 2010 2009

Ondansetron Oxybutynin Oxycodone hydrochloride Oxytocin

Pamidronate disodium

2011

Pantoprazole

2010

Paracetamol

Tab 500 mg; 1,000 Oral liq 120 mg per 5 ml Oral liq 250 mg per 5 ml

2011

Paraffin liquid with soft white paraffin Paroxetine hydrochloride Pergolide Perhexiline maleate

Eye oint with soft white paraffin Tab 20 mg Tab 0.25 mg Tab 1 mg Tab 100 mg

2010 2010 2011 2009

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 14

Sole Subsidised Supply Products – cumulative to May 2009

Generic Name

Phenoxymethylpenicillin (Penicillin V)

Presentation

Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap potassium salt 250 mg Cap potassium salt 500 mg Eye drops 0.12% Oral drops 10%, 30 ml OP Eye drops 1.4% Eye drops 3% Tab long-acting 600 mg Tab 1 mg, 2 mg & 5 mg Tab 1 mg; 500 tab Tab 2.5 mg; 500 tab Tab 5 mg; 500 tab Tab 20 mg; 500 tab Cassette Inj 1.5 mega u; 5 inj Tab 10 mg Tab 25 mg Tab 50 mg Tab 5 mg; 10 mg & 20 mg Tab 10 mg with hydroclorothiazide 12.5 mg Tab 20 mg with hydroclorothiazide 12.5 mg Tab 200 mg Tab 300 mg Oral liq 150 mg per 10 ml Cap 150 mg Tab 150 mg & 300 mg Nebuliser soln 1 mg per ml, 2.5 ml Nebuliser soln 2 mg per ml, 2.5 ml Oral liq 2 mg per 5 ml Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg Tab 5 mg Inj 0.9%, 5 ml & 10 ml Grans eff 4 g sachets Nasal spray 4% Tab 500 mg Tab EC 500 mg

Brand Name Expiry Date*

AFT AFT Cilicaine VK Cilicaine VK Prefrin Coloxyl Vistil Vistil Forte Span-K Apo-Prazo Apo-Prednisone Apo-Prednisone Apo-Prednisone Apo-Prednisone MDS Quick Card Cilicaine Allersoothe Apo-Pyridoxine Accupril Accuretic 10 Accuretic 20 Q 200 Q 300 Peptisoothe Mycobutin Arrow-Roxithromycin Asthalin Asthalin Salapin Duolin Apo-Selegiline AstraZeneca Ural Rex Salazopyrin Salazopyrin EN 2009 2010 2010 2009 2009 2010 2009 2009 2009 2010 2009 2009 2010

Phenylephrine hydrochloride Poloxamer Polyvinyl alcohol Potassium chloride Prazosin hydrochloride Prednisone

2010 2011 2011 2009 2010 2011

Pregnancy tests - HCG urine Procaine penicillin Promethazine Pyridoxine hydrochloride Quinapril Quinapril with hydroclorothiazide

2009 2011 2011 2009 2011 2011

Quinine sulphate Ranitidine hydrochloride Rifabutin Roxithromycin Salbutamol

Salbutamol with ipratropium bromide Selegiline hydrochloride Sodium chloride Sodium citro-tartrate Sodium cromoglycate Sulphasalazine

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 15

Sole Subsidised Supply Products – cumulative to May 2009

Generic Name

Syrup (pharmaceutical grade) Tar with triethanolamine lauryl sulphate and fluorescein sodium Temazepam Terbinafine Testosterone cypionate Tetracosactrin Timolol maleate

Presentation

Liq Soln 2.3%; 500 ml and 1,000 ml

Brand Name Expiry Date*

Midwest Pinetarsol 2010 2011

Tab 10 mg; 25 tab Tab 250 mg Inj long-acting 100 mg per ml, 10 ml Inj 250 mcg Inj 1 mg per ml, 1 ml Eye drops 0.25% Eye drops 0.5% Tab 10 mg Tab 50 mg Crm 0.02%; 100 g OP Oint 0.02%; 100 g OP Inj 40 mg per ml, 1 ml; 5 inj 0.1% in Dental Paste USP Ear drops 1 mg with nystatin 100,000 u, neomycin sulphate 2.5 mg and gramicidin 250 mcg per g Tab 300 mg; 50 tab Cap 300 mg Inj 50 mg per ml, 10 ml; 1 inj Inj 1 mg per ml, 1 ml Inj 1 mg per ml, 2 ml Tab (BPC cap strength) Tab, strong, BPC Purified for injection 20 ml Ointment BP Cap 220 mg; 100 cap Tab 7.5 mg

Normison Apo-Terbinafine Depo-Testosterone Synacthen Synacthen Depot Apo-Timop Apo-Timop Apo-Timol Apo-Thiamine Aristocort Aristocort Kenacort-A40 Oracort Kenacomb

2011 2011 2011 2011 2011 2009 2009 2011 2011 2009

Thiamine hydrochloride Triamcinolone acetonide

Triamcinolone acetonide with gramicidin, neomycin and nystatin Trimethoprim Ursodeoxycholic acid Vancomycin hydrochloride Vincristine sulphate Vitamins Vitamin B complex Water Zinc and castor oil Zinc sulphate Zopiclone May changes in bold type.

TMP Actigall Pacific Mayne Mayne Healtheries Apo-B-Complex Multichem PSM Zincaps Apo-Zopiclone

2011 2011 2011 2009 2009 2009 2009 2011 2011 2011

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated. 16

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings

Effective 1 May 2009

46 ATORVASTATIN – Additional subsidy by Special Authority see SA0788 below – Retail pharmacy See prescribing guideline on the preceding page ❋ Tab 80 mg .............................................................................. 16.28 30 (110.50) Lipitor TERAZOSIN HYDROCHLORIDE ❋ Tab 1 mg .................................................................................. 2.50 ❋ Tab 2 mg ................................................................................ 23.30 ❋ Tab 5 mg ................................................................................ 29.00 CO-TRIMOXAZOLE ❋ Oral liq trimethoprim 40 mg and sulphamethoxazole 200 mg per 5 ml – Up to 200 ml available on a PSO ........................................... 2.15 NORTRIPTYLINE HYDROCHLORIDE Tab 25 mg .............................................................................. 14.44 PACLITAXEL – PCT only – Specialist Inj 30 mg .............................................................................. 189.75 28 500 500

✔ Apo-Terazosin ✔ Apo-Terazosin ✔ Apo-Terazosin

100 ml 180 5

✔ Deprim

110 138 172

✔ Norpress ✔ Paclitaxel Ebewe

PAEDIATRIC ORAL FEED 1.5KCAL/ML – Special Authority see SA0896 above – Hospital pharmacy [HP3] Liquid (strawberry) .................................................................... 1.60 200 ml OP ✔ NutriniDrink Liquid (vanilla)........................................................................... 1.60 200 ml OP ✔ NutriniDrink PAEDIATRIC ORAL FEED WITH FIBRE 1.5KCAL/ML – Special Authority see SA0896 above – Hospital pharmacy [HP3] Liquid (strawberry) .................................................................... 1.60 200 ml OP ✔ NutriniDrink Multifibre Liquid (chocolate) ..................................................................... 1.60 200 ml OP ✔ NutriniDrink Multifibre Liquid (vanilla) .......................................................................... 1.60 200 ml OP ✔ NutriniDrink Multifibre

172

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions

Effective 1 May 2009

55 FRUSEMIDE FUROSEMIDE ❋ Tab 40 mg – Up to 30 tab available on a PSO .......................... 10.75 ❋ Tab 500 mg ............................................................................ 12.00 ❋‡ Oral liq 10 mg per ml............................................................. 10.66 ❋ Infusion ................................................................................. 481.40 ❋ Inj 10 mg per ml, 2 ml – Up to 5 inj available on a PSO ............ 29.50 CICLOPIROX OLAMINE CICLOPIROXOLAMINE a) Only on a prescription b) not in combination Nail soln 8% ........................................................................... 19.85 1,000 100 30 ml OP 5 50 ✔ Diurin 40 ✔ Diurin 500 ✔ Lasix ✔ Lasix ✔ Mayne

3.5 ml OP ✔ Batrafen

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price

Effective 1 May 2009

25 CALCIUM CARBONATE WITH AMINOACETIC ACID ❋ Tab 420 mg with aminoacetic acid 180 mg - Higher subsidy of $6.30 per 100 with Endorsement ........................................... 3.00 100 (6.30) Titralac Additional subsidy by endorsement is available for pregnant women. The prescription must be endorsed accordingly ACARBOSE ( subsidy and price) – Special Authority see SA0925 below – Retail pharmacy ❋ Tab 50 mg .............................................................................. 16.50 90 ✔ Glucobay ❋ Tab 100 mg ............................................................................ 26.70 90 ✔ Glucobay COPPER ( price) ❋ Tab Diagnostic – Not on a BSO .................................................. 5.02 (31.80) GLUCOSE OXIDASE ( price) Urine diagnostic test with peroxidase – Not on a BSO ................. 4.13 (8.65) 4.11 (6.26) GLUCOSE OXIDASE ( price) Urine diagnostic test with peroxidase, potassium iodide, sodium nitroprusside and aminoacetic acid – Not on a BSO ......................................................................... 4.53 (14.87) SODIUM NITROPRUSSIDE ( price) ❋ Urine diagnostic strip, buffered – Not on a BSO .......................... 3.40 (10.94) SIMVASTATIN ( subsidy)– See prescribing guidelines on page 45 ❋ Tab 10 mg ................................................................................ 0.68 (11.37) ❋ Tab 20 mg ................................................................................ 1.00 (11.67) ❋ Tab 40 mg ................................................................................ 1.78 (12.41) ❋ Tab 80 mg ................................................................................ 3.88 (14.39) SIMVASTATIN ( subsidy)– See prescribing guidelines on page 45 ❋ Tab 80 mg ................................................................................ 3.88 FUROSEMIDE ( subsidy and price) ❋ Tab 40 mg - Up to 30 tab available on a PSO ........................... 10.75 CICLOPIROXOLAMINE ( subsidy and price) a) Only on a prescription b) not in combination Nail soln 8% ........................................................................... 19.85 Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber. 36 OP Clinitest 50 strip OP Clinistix Diastix

50 strip OP Keto-Diastix 50 strip OP Ketostix 30 30 30 30 Lipex 30 1,000

✔ SimvaRex Lipex ✔ SimvaRex Lipex ✔ SimvaRex Lipex

47 55 59

✔ SimvaRex ✔ Diurin 40

3.5 ml OP ✔ Batrafen

▲

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price - effective 1 May 2009 (continued)

85 86 ERYTHROMYCIN ETHYL SUCCINATE ( subsidy and price) Tab 400 mg - Up to 30 tab available on a PSO ........................ 16.95 AMOXYCILLIN CLAVULANATE ( subsidy) Tab amoxycillin 500 mg with potassium clavulanate 125 mg - Up to 30 tab available on a PSO ........................................... 5.02 (6.40) HYDROXYCHLOROQUINE SULPHATE ( subsidy and price) ❋ Tab 200 mg ............................................................................ 22.50 IBUPROFEN ( subsidy) ❋ Tab 200 mg .............................................................................. 1.60 (1.78) 100 ✔ E-Mycin

20 Augmentin 100 100 I-Profen

88 99

✔ Plaquenil

108

METHADONE HYDROCHLORIDE ( subsidy and price) a) Only on a controlled drug form b) No patient co-payment payable c) Extemporaneously compounded methadone will only be reimbursed at the rate of the cheapest form available (methadone powder, not methadone tablets) d) For methadone hydrochloride oral liquid refer, page 162 ‡ Oral liq 2 mg per ml ................................................................... 5.95 200 ml ✔ Biodone ‡ Oral liq 5 mg per ml ................................................................... 5.55 200 ml ✔ Biodone Forte ‡ Oral liq 10 mg per ml .................................................................. 8.95 200 ml ✔ Biodone Extra Forte ENTACAPONE ( subsidy and price) ▲ Tab 200 mg .......................................................................... 116.00 LEVOCABASTINE ( price) Eye drops 0.5 mg per ml ........................................................... 8.71 (10.34) 100 4 ml OP Livostin

117 154

✔ Comtan

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Description

Effective 1 May 2009

86 BENZATHINE BENZYLPENICILLIN Inj 1.2 mega u per 2 2.3 ml – Up to 5 inj available on a PSO... 200.00 10 ✔ Bicillin LA

Changes to Sole Subsidised Supply

Effective 1 May 2009

For the list of new Sole Subsidised Supply products effective 1 May 2009 refer to the bold entries in the cumulative Sole Subsidised Supply table pages 8-16.

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items

Effective 1 May 2009

49 DOXAZOSIN MESYLATE ❋ Tab 2 mg ................................................................................. 4.81 Note – the 500 tablet pack listed 1 November 2008 OESTRADIOL VALERATE – See prescribing guideline ❋ Tab 2 mg ................................................................................. 4.12 PARACETAMOL ❋ Tab 500 mg – Up to 30 tab available on a PSO .......................... 1.38 (14.67) 100 ✔ Apo-Doxazosin

77 107

28 150

✔ Progynova

Panadol

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted

Effective 1 August 2009

84 MEBENDAZOLE Tab 100 mg .............................................................................. 2.53 (7.43) 4 Vermox

Effective 1 October 2009

49 TERAZOSIN HYDROCHLORIDE ❋ Tab 2 mg .................................................................................. 1.48 (4.66) ❋ Tab 5 mg .................................................................................. 1.91 (5.60) AZATHIOPRINE – Retail pharmacy-Specialist ❋ Tab 50 mg .............................................................................. 25.00 28 Hytrin 28 Hytrin 100 ✔ Thioprine

142

Effective 1 November 2009

172 PAEDIATRIC ORAL FEED 1.5KCAL/ML – Special Authority see SA0896 above – Hospital pharmacy [HP3] Liquid (strawberry) .................................................................... 1.60 200 ml OP ✔ Fortini Liquid (vanilla)........................................................................... 1.60 200 ml OP ✔ Fortini PAEDIATRIC ORAL FEED WITH FIBRE 1.5KCAL/ML – Special Authority see SA0896 above – Hospital pharmacy [HP3] Liquid (chocolate) ..................................................................... 1.60 200 ml OP ✔ Fortini Multifibre Liquid (strawberry) .................................................................... 1.60 200 ml OP ✔ Fortini Multifibre Liquid (vanilla)........................................................................... 1.60 200 ml OP ✔ Fortini Multifibre

172

Effective 1 December 2009

25 CALCIUM CARBONATE WITH AMINOACETIC ACID ❋ Tab 420 mg with aminoacetic acid 180 mg – Higher subsidy of $38.73 per 1000 with Endorsement ................................. 30.00 (38.73) NORTRIPTYLINE HYDROCHLORIDE Tab 25 mg .............................................................................. 20.06

1,000 Titralac 250 ✔ Norpress

110

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Section H changes to Part I

Effective 1 May 2009

14 Discretionary Community Supply Pharmaceuticals 8.1 Discretionary Community Supply Pharmaceuticals are deemed to include every medicine, therapeutic medical device, or related product or related thing listed in Section H Part IV of the Schedule. 8.2 PHARMAC may, in its discretion, list any pharmaceutical that is not a Community Pharmaceutical as a Discretionary Community Supply Pharmaceutical, including a pharmaceutical that PHARMAC is made aware of by HPAC, the Exceptional Circumstances Panel, a DHB Hospital or relevant hospital personnel. 8.3 A DHB Hospital may use its discretion to purchase Discretionary Community Supply Pharmaceuticals for use in the community, provided that, if the patient being treated with a Discretionary Community Supply Pharmaceutical usually resides in a district other than that within the jurisdiction of the DHB initiating the treatment, then the DHB initiating the treatment must either agree to fund any on-going treatment required once the patient has returned to his/her usual DHB, or obtain written consent from the DHB or DHBs in which the patient will reside following the commencement of treatment. 8.4 The funding of a Discretionary Community Supply Pharmaceutical for use in the community will be sourced from the relevant DHBs own budget. For the avoidance of doubt, the Discretionary Community Supply Pharmaceutical is not a Community Pharmaceutical and funding is not available for Discretionary Community Supply Pharmaceuticals from the Pharmaceutical Budget. 8.5 Subject to rule 8.6, DHB Hospitals must not fund for use in the community, any pharmaceuticals that are not Discretionary Community Supply Pharmaceuticals unless they have been approved under Hospital Exceptional Circumstances. 8.6 DHB Hospitals may fund from their own budgets, any Pharmaceutical that is listed in Sections A-G of the Pharmaceutical Schedule without Hospital Exceptional Circumstances (HEC) approval provided that: (a) the condition for which that Pharmaceutical is supplied is consistent with any restrictions applying to that Pharmaceutical in Section A-G of the Pharmaceutical Schedule; and (ba) (i) up to 5 days treatment, or one original pack, (where inappropriate to provide less); or (ii) more than 5 days treatment, provided that the relevant DHB Hospital has a dispensing for discharge policy and the quantity supplied is in accordance with that policy; and (b) the Pharmaceutical is supplied consistent with any restrictions applying to that Pharmaceutical in Section A-G of the Pharmaceutical Schedule. Note dispensing for discharge as described in rule 8.6 is at the discretion of individual DHBs.

continued... Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

S29

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II

Effective 1 May 2009

ACARBOSE (new listing and HSS) Tab 50 mg......................................Glucobay Tab 100 mg....................................Glucobay CO-TRIMOXAZOLE (new listing) Oral liq 240 mg per 5 ml .................Deprim ENTACAPONE (new listing and HSS) Tab 200 mg....................................Comtan 16.50 26.70 2.15 116.00 90 90 100 ml 100 100 1% 1% 1% Jul-09 Jul-09 Jul-09 (B) (B) Apo-Frusemide Frusehexal Frusid (B) 1% 1% Jul-09 Jul-09 (B) (B)

ERYTHROMYCIN ETHYL SUCCINATE ( price and HSS) Tab 400 mg ...................................E-Mycin 16.95

FRUSEMIDE FUROSEMIDE (Change in chemical name,  price and HSS) Tab 40 mg......................................Diurin 40 10.75 1,000

HYDROXYCHLOROQUINE SULPHATE ( price and HSS) Tab 200 mg....................................Plaquenil 22.50 LIGNOCAINE WITH PRILOCAINE (delisting) Patch 2.5% with prilocaine 2.5% .....EMLA 10.40

100 2 200 ml 200 ml 200 ml 30 30 30

Jul-09

METHADONE HYDROCHLORIDE ( price and HSS) Oral liq 2 mg per ml ........................Biodone 5.95 Oral liq 5 mg per ml ........................Biodone Forte 5.55 Oral liq 10 mg per ml .....................Biodone Extra Forte8.95 OMEPRAZOLE (addition of HSS) Cap 10 mg .....................................Dr Reddy’s Omeprazole Cap 20 mg .....................................Dr Reddy’s Omeperazole Cap 40 mg .....................................Dr Reddy’s Omeprazole OMEPRAZOLE (delisting) Inf 40 mg .......................................Losec IV 2.14 3.05 3.59

1% 1% 1% 1% 1% 1%

Jul-09 Jul-09 Jul-09 May-09 May-09 May-09

(B) (B) (B) Losec Omezol Losec Omezol Losec Omezol

38.65

5 3.50 237 ml

SPECIAL FOOD SUPPLEMENT (new listing) Liquid, 237 ml ................................Impact Advanced Recovery Vanilla and Chocolate SPECIAL FOOD SUPPLEMENT (delisting) Powder, sachet 74 g.......................Oral Impact 17.50

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 April 2009

AMIKACIN SULPHATE (delisting date) Inj 250 mg per ml, 2 ml ..................Amikin Note- This product will be delisted 1 July 2009 15.00 1 1% Sept-06 (B)

APOMORPHINE HYDROCHLORIDE (new listing) Inj 10 mg per ml, 2 ml ....................Apomine 50.43 5 Note – The Mayne brand of Apomorphine hydrochloride inj 10 mg per ml, 1 ml will be delisted from 1 October 2009. ATOMOXETINE HYDROCHLORIDE (new listing) Cap 10 mg .....................................Strattera Cap 18 mg .....................................Strattera Cap 25 mg .....................................Strattera Cap 40 mg .....................................Strattera Cap 60 mg .....................................Strattera Cap 80 mg .....................................Strattera Cap 100 mg ...................................Strattera CLOZAPINE (new listing) Tab 25 mg......................................Clozaril Tab 100 mg ...................................Clozaril 107.03 107.03 107.03 107.03 107.03 139.11 139.11 26.74 69.30 28 28 28 28 28 28 28 100 100

DANAZOL (new listing) Cap 100 mg ...................................Azol 56.66 100 Note - D Zol brand of Danazol cap 100 mg 30 pack size to be delisted 1 October 2009 DIAZEPAM ( price) Rectal tubes 5 mg ..........................Stesolid Rectal tubes 10 mg ........................Stesolid 25.05 30.50 5 5 1 1 1% 1% Jun-09 Jun-09 Gemzar Hospira Gemzar Hospira Losec Losec IV

GEMCITABINE HYDROCHLORIDE (new listing and HSS) Inj 200 mg......................................Gemcitabine Ebewe49.00 Inj 1 g.............................................Gemcitabine Ebewe245.00 OMEPRAZOLE (addition of HSS) Inj 40 mg........................................Dr Reddy’s Omeprazole Inf 40 mg .......................................Dr Reddy’s Omeprazole PARACETAMOL ( price) Suppos 125 mg..............................Panadol Suppos 250 mg..............................Panadol

38.20 38.65

5 5

1% 1%

May-09 May-09

7.49 14.40

20 20

ROPINIROLE (new listing and HSS) Tab 0.25 mg ..................................Ropin 7.90 84 1% June-09 Requip Tab 1 mg .......................................Ropin 40.32 84 1% June-09 Requip Tab 2 mg .......................................Ropin 60.72 84 1% June-09 Requip Tab 5 mg .......................................Ropin 90.00 84 1% June-09 Requip Note – Requip tab 0.25mg, 1 mg, 2 mg and 5mg and Requip Starter pack and Follow-on pack will all be delisted 1 September 2009 Products with Hospital Supply Status (HSS) are in bold. (B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 April 2009 (continued)

VERAPAMIL (delisting) Tab 40 mg .....................................Verpamil 4.75 100

Section H changes to Part IV

Effective 1 May 2009

INDOMETHACIN Cap 50 mg S29 For any indication approved by the hospital service SPECIAL FOOD SUPPLEMENT (delisting) Powder, sachet 74 g Oral Impact Three sachets per day for 5-7 days prior to major gastrointestinal or head or neck surgery

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Index

Pharmaceuticals and brands A Acarbose ..................................................... 19, 25 Amikacin sulphate .............................................. 26 Amikin ............................................................... 26 Amoxycillin clavulanate ...................................... 20 Apo-Doxazosin................................................... 22 Apomine ............................................................ 26 Apomorphine hydrochloride ............................... 26 Apo-Terazosin.................................................... 17 Atomoxetine hydrochloride ................................. 26 Atorvastatin........................................................ 17 Augmentin ......................................................... 20 Azathioprine ....................................................... 23 Azol ................................................................... 26 B Batrafen ....................................................... 18, 19 Benzathine benzylpenicillin ................................. 21 Bicillin LA........................................................... 21 Biodone ....................................................... 20, 25 Biodone Extra Forte ...................................... 20, 25 Biodone Forte............................................... 20, 25 C Calcium carbonate with aminoacetic acid ..... 19, 23 Ciclopirox olamine.............................................. 18 Ciclopiroxolamine......................................... 18, 19 Clinistix .............................................................. 19 Clinitest.............................................................. 19 Clozapine ........................................................... 26 Clozaril .............................................................. 26 Comtan ........................................................ 20, 25 Copper............................................................... 19 Co-trimoxazole ............................................. 17, 25 D Danazol.............................................................. 26 Deprim......................................................... 17, 25 Diastix ............................................................... 19 Diazepam........................................................... 26 Diurin 40 ................................................ 18, 19, 25 Diurin 500 .......................................................... 18 Doxazosin mesylate ........................................... 22 Dr Reddy’s Omeprazole................................ 25, 26 E EMLA................................................................. 25 E-Mycin ....................................................... 20, 25 Entacapone .................................................. 20, 25 Erythromycin ethyl succinate ........................ 20, 25 F Fortini ................................................................ 23 Fortini Multifibre ................................................. 23 Frusemide .................................................... 18, 25 Furosemide ............................................ 18, 19, 25 G Gemcitabine Ebewe............................................ 26 Gemcitabine hydrochloride ................................. 26 Glucobay ..................................................... 19, 25 Glucose oxidase................................................. 19 H Hydroxychloroquine sulphate........................ 20, 25 Hytrin................................................................. 23 I Ibuprofen ........................................................... 20 Impact Advanced Recovery Vanilla and Chocolate 25 Indomethacin ..................................................... 27 I-Profen ............................................................. 20 K Keto-Diastix ....................................................... 19 Ketostix.............................................................. 19 L Lasix .................................................................. 18 Levocabastine .................................................... 20 Lignocaine with prilocaine .................................. 25 Lipex.................................................................. 19 Lipitor ................................................................ 17 Livostin .............................................................. 20 Losec IV ............................................................ 25 M Mebendazole...................................................... 23 Methadone hydrochloride ............................. 20, 25 N Norpress ...................................................... 17, 23 Nortriptyline hydrochloride............................ 17, 23 NutriniDrink ........................................................ 17 NutriniDrink Multifibre ......................................... 17 O Oestradiol valerate.............................................. 22 Omeprazole.................................................. 25, 26 Oral Impact .................................................. 25, 27 P Paclitaxel ........................................................... 17 Paclitaxel Ebewe ................................................ 17 Paediatric oral feed 1.5kcal/ml............................ 17 Paediatric oral feed with fibre 1.5kcal/ml....... 17, 23 Paediatric oral feed 1.5kcal/ml............................ 23 Panadol ....................................................... 22, 26 Paracetamol................................................. 22, 26 Plaquenil ...................................................... 20, 25 Progynova ......................................................... 22 R Ropin ................................................................. 26 Ropinirole .......................................................... 26 S SimvaRex .......................................................... 19 Simvastatin ........................................................ 19

Index

Pharmaceuticals and brands Sodium nitroprusside ......................................... 19 Special food supplement .............................. 25, 27 Stesolid ............................................................. 26 Strattera ............................................................. 26 T Terazosin hydrochloride ............................... 17, 23 Thioprine ........................................................... 23 Titralac ........................................................ 19, 23 V Verapamil .......................................................... 27 Vermox .............................................................. 23 Verpamil ............................................................ 27

Pharmaceutical Management Agency Level 9, Cigna House, 40 Mercer Street, PO Box 10-254, Wellington 6143, New Zealand Phone: 64 4 460 4990 - Fax: 64 4 460 4995 - www.pharmac.govt.nz Freephone Information line (9am-5pm weekdays) 0800 66 00 50

PHARMAC is the Government agency responsible for deciding which medicines are subsidised for New Zealanders. It manages spending on pharmaceuticals for the District Health Boards, and ensures that a comprehensive list of medicines (the Pharmaceutical Schedule) is subsidised for New Zealanders, and that the list of medicines continues to grow to meet the needs of patients.

Metadata

Title

Schedule Update - effective 1 May 2009

Abstract

Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 May 2009 Section H cumulative for April and May 2009. Contents Summary of PHARMAC decision effective 1 May 2009…. 3 Changes to list of approved specialists for antiretroviral Special Authority…

Page 1

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.